Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$172,920,735
+$10,890,503 QoQ
Shares Held
911,933
+11.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#102
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SATURNA CAPITAL CORP holds $1,106,352,364 across 8 Drug Manufacturers - General names. AZN ranks #3 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
460,411 | $552,230,811 | |
| 2 | ABBV |
AbbVie Inc.
|
958,069 | $241,088,483 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
911,933 | $172,920,735 | |
| 4 | JNJ |
Johnson & Johnson
|
229,115 | $58,188,336 | |
| 5 | NVS |
Novartis AG
|
311,392 | $48,801,354 | |
| 6 | MRK |
Merck & Co., Inc.
|
197,643 | $25,397,125 | |
| 7 | NVO |
Novo Nordisk A S
|
116,291 | $5,574,990 | |
| 8 | GSK |
GSK plc
|
41,025 | $2,150,530 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,920,735 | 911,933 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $162,030,232 | 821,571 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||